Abaloparatide (Tymlos): Bone-Building Peptide, Label Facts
Abaloparatide is an approved PTHrP analogue that builds bone and cut new vertebral fractures by 86% in the ACTIVE trial. Label dosing, side effects, limits.
Peptide Therapy
Specialty Peptides
5 articles on Specialty Peptides by Dr. med. univ. Julian Douwes: Abaloparatide (Tymlos): Bone-Building Peptide, Label Facts; and more.
01
02
ARA-290 (Cibinetide): Small Trials in Nerve Pain
ARA-290 (cibinetide) is an EPO-derived peptide tested in small trials for sarcoidosis and diabetic small fiber neuropathy. Doses, results and limits.
03
Glutathione: What the Bioavailability Data Actually Show
IV, liposomal, nebulised and intranasal glutathione compared on real bioavailability and trial data, with dosing protocols, the FDA endotoxin alerts and risks.
04
PNC-27: Laboratory Research Only, No Human Trials
PNC-27 is a p53-derived peptide studied in cell lines and mice. No human trial has been published or registered. What was tested, what is unknown.
05
VIP Peptide for CIRS: The Vasoactive Intestinal Peptide Protocol
Vasoactive intestinal peptide (VIP) is a neuropeptide used in the final phase of CIRS treatment. Learn dosing, eligibility criteria, lab markers, and clinical evidence.
